Paclitero 100mg Injection

About Paclitero 100mg Injection

Paclitero 100mg Injection is an anticancer medication used to treat various cancers, including breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS-related Kaposis sarcoma. It works by disrupting the growth and division of cancer cells, helping to slow or stop the progression of the disease. Depending on the type and stage of cancer, Paclitero 100mg Injection may be administered alone or in combination with other chemotherapy medicines to improve treatment outcomes. This medication is not recommended for patients with severe liver disease, uncontrolled infections, or significantly low white blood cell or platelet counts. It is also generally not suitable for children and adolescents under 18 years of age. Before beginning treatment, patients should inform their healthcare provider about any history of heart disease or other medical conditions, as additional monitoring may be necessary. Serious allergic reactions can occur during administration, making treatment under close medical supervision essential. Patients of reproductive age should use effective contraception during therapy and for at least six months after the final dose to prevent pregnancy-related risks. Additionally, because the formulation may contain alcohol, individuals with alcoholism or alcohol-related health concerns should discuss potential risks with their doctor before receiving Paclitero 100mg Injection. Regular follow-up and monitoring throughout treatment help ensure safety and maximize therapeutic benefits.